Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 12, 2010
[Testicular germ cell tumors late relapses]X Durand, C Avances, A Flechon, et al.
The Netherlands Journal of Medicine|February 11, 2004
Coagulopathy in prostate cancerC de la Fouchardière, A Flechon, J P Droz
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 5, 2013
[Chemotherapy in male external genital organs (testicular and penile cancer)]J-L Deville, A Flechon, F Bruyère, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 31, 2011
[The role of chemotherapy in the management of bladder cancer]N Ismaili, M Amzerin, S Elmajjaoui, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 9, 2014
[Impact of neoadjuvant chemotherapy on therapeutic management of muscle-invasive bladder cancer]V Meyer, A Flechon, S Tartas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 10, 2014
[Management of testicular teratoma: update by the Oncology Committee of the French Urology Association, section of External Genital Organs (CCAFU-OGE)]C Avances, P Camparo, X Durand, et al.
Bulletin Du Cancer|May 22, 2009
Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosisN Ismaili, S Arifi, A Flechon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 14, 2018
[Non-palpable testicular tumors in adults: A management based on imaging? Issue from the French Urologic Association Genital Cancer committee's edit]L Rocher, L Feretti, P Camparo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumorsC Theodore, C Chevreau, Y Yataqhene, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2011
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancerK Fizazi, J S De Bono, A Flechon, et al.
Pageof 2